Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Stromal Tumors × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 372 Polycystic Ovary Syndrome 40 Endometrial Neoplasms 22 Neoplasm Metastasis 21 Ovarian Neoplasms 16 Neoplasms 14 Infertility 11 Advanced Breast Cancer 10 Fallopian Tube Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Recurrence 7 Osteoporosis 7 Carcinoma, Ductal, Breast 7 Breast Neoplasms, Male 7 Breast Diseases 7 Triple Negative Breast Neoplasms 6 Carcinoma, Lobular 6 Breast Carcinoma In Situ 6 Prostatic Neoplasms 4 Leiomyoma 4 Infertility, Female 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Cancer Metastatic 4 Arthralgia 4 Obesity 3 Neoplasms, Hormone-Dependent 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2

Interventions

exemestane 1 Vorinostat 1 Therapeutics 1 Surgical Procedures, Operative 1 Mifepristone 1 Letrozole 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03624244 2026-02-17

BFR-ESS

Centre Leon Berard

Phase 2 Recruiting

Endometrial Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡